A carregar...
For submission at the Journal of controlled release Anti-FLT3 Nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics
FLT3 receptor is an important therapeutic target in acute myeloid leukemia due to high incidence of mutations associated with poor clinical outcome. Targeted therapies against the FLT3 receptor, including small-molecule FLT3 tyrosine kinase inhibitors (TKIs) and anti-FLT3 antibodies, have demonstrat...
Na minha lista:
| Publicado no: | J Control Release |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473778/ https://ncbi.nlm.nih.gov/pubmed/32428520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.05.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|